DNA chip evaluation as a diagnostic device
To use DNA chip as a diagnostic device, it should be evaluated and approved as a medical device. In this study, we developed a guideline for DNA chip evaluation and evaluated a commercialized DNA chip according to the guideline. This guideline consists of three parts: evaluation of quality control system, analytical performance, and clinical performance of DNA chips. First, the quality control system should be evaluated in the aspect of material, manufacturing process, and final product. In addition, the validation of expiration date, storing condition, and required reagents is needed to confirm the quality control system. Second, the analytical performance of DNA chip should be evaluated by accuracy, sensitivity, reproducibility, and cut-off value. Third, the clinical performance of DNA chip should be evaluated by clinical specificity, clinical sensitivity, positive and negative predictive value. We evaluated the accuracy and lot-to-lot reproducibility of a commercial HPV detection DNA chip. We analyzed 20 clinical samples. The accuracy of a DNA chip was evaluated by comparing the test results to DNA sequencing results. Lot-to-lot reproducibility was assessed by consistency of results from three different lots. The accuracy and reproducibility of the HPV DNA chip were almost 100%. In addition to the accuracy and reproducibility, the cut-off value of DNA chip was above 2.3 [Signal to Noise Ratio (SNR)≥2.3].
유료 다운로드의 경우 해당 사이트의 정책에 따라 신규 회원가입, 로그인, 유료 구매 등이 필요할 수 있습니다. 해당 사이트에서 발생하는 귀하의 모든 정보활동은 NDSL의 서비스 정책과 무관합니다.
원문복사신청을 하시면, 일부 해외 인쇄학술지의 경우 외국학술지지원센터(FRIC)에서
무료 원문복사 서비스를 제공합니다.
NDSL에서는 해당 원문을 복사서비스하고 있습니다. 위의 원문복사신청 또는 장바구니 담기를 통하여 원문복사서비스 이용이 가능합니다.
- 이 논문과 함께 출판된 논문 + 더보기